Scopolamine-induced convulsions in food given fasted mice: effects of physostigmine and MK-801


Enginar N. , NURTEN A. , YAMANTURK P. , KOYUNCUOGLU H.

EPILEPSY RESEARCH, cilt.28, sa.2, ss.137-142, 1997 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 28 Konu: 2
  • Basım Tarihi: 1997
  • Doi Numarası: 10.1016/s0920-1211(97)00041-7
  • Dergi Adı: EPILEPSY RESEARCH
  • Sayfa Sayıları: ss.137-142

Özet

We recently reported that scopolamine pretreated mice fasted for 48 h developed clonic convulsions soon after they were allowed to eat a small amount of food for 30 s. The present experiments were performed to determine whether animals also develop convulsions when they were allowed to eat ad libitum and to find some evidence for the contribution of the cholinergic and/or glutamatergic systems in the underlying mechanism(s) of convulsions. Animals fasted for 48 h were treated with 3 mg/kg scopolamine or saline. Twenty minutes later, they were allowed to eat either ad libitum or a small portion of food for 30 s. Scopolamine pretreated animals after starting to eat ad libitum or a small amount in a restricted time developed convulsions in a few minutes, the incidence being 76 and 54%, respectively. Pretreatment of 0.17 mg/kg MK-801, the noncompetitive NMDA antagonist, decreased the incidence of scopolamine-induced convulsions (22%) without affecting latency to the onset of seizures, Pretreatment of 0.1 mg/kg physostigmine, the cholinesterase inhibitor, changed neither the incidence (90%) nor latency to the onset of scopolamine-induced convulsions. (C) 1997 Elsevier Science B.V.